Health

New Covid vaccine coming, Sanofi and Gsk ready to seek approval

ADVERTISING
Rome, February 25 – Covid therapies could soon be enriched with a new vaccine. In light of the positive data from the Sars CoV 2 vaccine study and the phase 3 study developed by Sanofi together with GSK, the two companies announce that they are ready to present the test results to both continue to seek approval in Europe and the United States.

ADVERTISING

ADVERTISING
1 of 6